Formula Growth’s Cambrex Corporation CBM Stock Holding History

Formula Growth’s Portfolio CBM Stock Details CBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-19,727	Closed	-$923K	–	167
2019 Q2	$923K	Hold	19,727	–	–	0.13%	127
2019 Q1	$766K	Hold	19,727	–	–	0.11%	131
2018 Q4	$745K	Hold	19,727	–	–	0.12%	123
2018 Q3	$1.35M	Hold	19,727	–	–	0.15%	113
2018 Q2	$1.03M	Hold	19,727	–	–	0.11%	129
2018 Q1	$1.03M	Hold	19,727	–	–	0.12%	134
2017 Q4	$947K	Hold	19,727	–	–	0.12%	115
2017 Q3	$1.08M	Hold	19,727	–	–	0.17%	114
2017 Q2	$1.18M	Hold	19,727	–	–	0.2%	108
2017 Q1	$1.09M	Hold	19,727	–	–	0.23%	114
2016 Q4	$1.06M	Hold	19,727	–	–	0.25%	99
2016 Q3	$877K	Buy	+19,727	New	+$960K	0.2%	132

Other funds holding CBM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACM

American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return

Formula Growth's CBM Position: Q3 2019 in Review

Formula Growth sold out of Cambrex Corporation (CBM) in Q3 2019, closing a stake of 19,727 shares — an estimated $923K sold.

Formula Growth first reported a position in CBM in Q3 2016 and held it in 12 quarters. The position peaked at $1.35M in Q3 2018. 201 funds tracked by Wall St. Rank hold CBM as of Q3 2019.

Formula Growth reported no remaining Cambrex Corporation position as of Q3 2019 after selling out during the quarter.
Formula Growth sold 19,727 Cambrex Corporation shares in Q3 2019, an estimated $923K.
Formula Growth first reported a position in Cambrex Corporation in Q3 2016 and held it in 12 quarters.
Formula Growth's Cambrex Corporation position peaked at $1.35M in Q3 2018.
201 funds tracked by Wall St. Rank held Cambrex Corporation as of Q3 2019.

Based on Formula Growth's 13F filing for Q3 2019, filed 14 Nov 2019.